A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice

BACKGROUND: Although DAAs hold promise to significantly reduce rates of chronic HCV infections, its eradication still requires development of an effective vaccine. Prolonged T cell responses and cross neutralizing antibodies are ideal for vaccination against the infection. We aimed to design and syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Reham M., Moustafa, Rehab I., Abdelhafez, Tawfeek H., El-Shenawy, Reem, El-Abd, Yasmine, Bader El Din, Noha G., Dubuisson, Jean, El Awady, Mostafa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833294/
https://www.ncbi.nlm.nih.gov/pubmed/31690267
http://dx.doi.org/10.1186/s12879-019-4571-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833294/
https://www.ncbi.nlm.nih.gov/pubmed/31690267
http://dx.doi.org/10.1186/s12879-019-4571-5

Ejemplares similares